Published in J Vasc Surg on February 01, 2003
Development of small-diameter vascular grafts. World J Surg (2007) 1.27
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater (2009) 1.20
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter (2010) 1.15
Polymeric coatings that mimic the endothelium: combining nitric oxide release with surface-bound active thrombomodulin and heparin. Biomaterials (2007) 1.00
Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med (2010) 0.99
Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination. Ann Surg (2005) 0.99
Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials (2009) 0.94
Crosslinked urethane doped polyester biphasic scaffolds: Potential for in vivo vascular tissue engineering. J Biomed Mater Res A (2010) 0.93
In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications. J Biomed Mater Res A (2010) 0.92
Polyurethane with tethered copper(II)-cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols. Biomaterials (2008) 0.91
Growth of outgrowth endothelial cells on aligned PLLA nanofibrous scaffolds. J Mater Sci Mater Med (2009) 0.88
Superhydrophobic effect on the adsorption of human serum albumin. Acta Biomater (2008) 0.86
A systematic procedure to build a relaxed dense-phase atomistic representation of a complex amorphous polymer using a coarse-grained modeling approach. Polymer (Guildf) (2009) 0.86
Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia. J Artif Organs (2011) 0.83
The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts. BMC Cardiovasc Disord (2012) 0.82
A bilinear stress-strain relationship for arteries. Biomaterials (2006) 0.82
Treatment of rabbit carotid aneurysms by hybrid stents (microporous thin polyurethane-covered stents): preservation of side-branches. J Biomater Appl (2013) 0.81
Using a type 1 collagen-based system to understand cell-scaffold interactions and to deliver chimeric collagen-binding growth factors for vascular tissue engineering. J Investig Med (2010) 0.81
The in vivo blood compatibility of bio-inspired small diameter vascular graft: effect of submicron longitudinally aligned topography. BMC Cardiovasc Disord (2013) 0.81
Tissue-engineered graft constructed by self-derived cells and heterogeneous acellular matrix. J Zhejiang Univ Sci B (2006) 0.80
Polymeric materials for tissue engineering of arterial substitutes. Vascular (2009) 0.80
Proteins, platelets, and blood coagulation at biomaterial interfaces. Colloids Surf B Biointerfaces (2014) 0.79
Quantitative grafting of peptide onto the nontoxic biodegradable waterborne polyurethanes to fabricate peptide modified scaffold for soft tissue engineering. J Mater Sci Mater Med (2011) 0.79
Formulation and characterization of a porous, elastomeric biomaterial for vocal fold tissue engineering research. Ann Otol Rhinol Laryngol (2014) 0.76
Citrate-Based Biomaterials and Their Applications in Regenerative Engineering. Annu Rev Mater Res (2015) 0.76
Scaffolds in vascular regeneration: current status. Vasc Health Risk Manag (2015) 0.76
Grafting of poly(ethylene glycol) monoacrylates on polycarbonateurethane by UV initiated polymerization for improving hemocompatibility. J Mater Sci Mater Med (2012) 0.76
Effect of hyaluronic acid incorporation method on the stability and biological properties of polyurethane-hyaluronic acid biomaterials. J Mater Sci Mater Med (2013) 0.75
Bacterial translocation across ePTFE vascular graft surfaces. J Infect (2010) 0.75
Enhancement of capillary and cellular ingrowth in ePTFE implants with a proangiogenic recombinant construct derived from fibronectin. J Biomed Mater Res A (2010) 0.75
Clinical results of biologic prosthesis: A systematic review and meta-analysis of comparative studies. Ann Med Surg (Lond) (2017) 0.75
Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation. Am J Surg (2006) 1.19
Telomerase expression in somatic cells. Lancet (2005) 1.11
Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res (2009) 1.06
Characterization of type I collagen gels modified by glycation. Biomaterials (2008) 1.04
In vitro models of angiogenesis. World J Surg (2007) 1.02
The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials (2009) 1.02
Therapeutic neovascularization: contributions from bioengineering. Tissue Eng (2005) 1.00
Dynamic quantitative visualization of single cell alignment and migration and matrix remodeling in 3-D collagen hydrogels under mechanical force. Biomaterials (2011) 0.99
Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. J Biomed Mater Res A (2009) 0.99
Molecular mediators of angiogenesis. J Burn Care Res (2010) 0.98
Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials (2009) 0.94
Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells. Am J Surg (2010) 0.93
Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). Am J Surg (2004) 0.90
Growing a living blood vessel: insights for the second hundred years. Biomaterials (2007) 0.88
R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue. J Vasc Surg (2003) 0.87
Characterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogels. J Biomed Mater Res A (2010) 0.86
Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials (2007) 0.86
Improving endothelial healing with novel chimeric mitogens. Am J Surg (2006) 0.84
Paclitaxel inhibits ureteral smooth muscle cell proliferation and collagen production in the absence of cell toxicity. J Urol (2011) 0.81
Using a type 1 collagen-based system to understand cell-scaffold interactions and to deliver chimeric collagen-binding growth factors for vascular tissue engineering. J Investig Med (2010) 0.81
Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Am J Surg (2003) 0.79
Three-dimensional 10% cyclic strain reduces bovine aortic endothelial cell angiogenic sprout length and augments tubulogenesis in tubular fibrin hydrogels. J Tissue Eng Regen Med (2010) 0.79
Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. J Vasc Surg (2004) 0.78
Analyzer-based phase-contrast x-ray imaging of carotid plaque microstructure. Am J Surg (2012) 0.78
In vivo remodeling: breakout session summary. Ann N Y Acad Sci (2002) 0.76
Commentary. Synthetic vascular prosthesis impregnated with mesenchymal stem cells overexpressing endothelial nitric oxide synthase. Perspect Vasc Surg Endovasc Ther (2007) 0.75
Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res (2013) 0.75
The effect of intraoperative duplex on the management of postoperative stroke. Surgery (2002) 0.75
Same-evening discharge after carotid endarterectomy: our initial experience. J Vasc Surg (2004) 0.75
Vascular grafts. Expert Rev Cardiovasc Ther (2003) 0.75
Comparison of standard carotid endarterectomy with Dacron patch angioplasty versus eversion carotid endarterectomy during a 4-year period. Am Surg (2004) 0.75
There may be nothing new under the sun, but this is ridiculous. J Vasc Surg (2010) 0.75